Audiobook on ElevenReader (Listen)
Download Full Document (PDF)
Life-Coherent Immunology (PDF) (PPT)
Reseeing Chronic Immune Disease (PDF) (PPT)
Deep Dive | Why your immune system gets stuck
Debate | Chronic Disease Is Unfinished Living
Critique | Clinical Blueprints for Life-Coherent Systems Immunology
Responding to the Critique (PDF)
Explainer | Life-Coherent Immunity
Cinematic | Unfinished Living: The 5E Architecture of Immune Coherence
Click on infographic to enlarge
Executive Summary
Life-Coherent Systems Immunology proposes an organism-centered framework for understanding chronic immune-mediated disease. It begins from a clinical concern: modern immunology has generated powerful disease categories and molecular explanations, yet many chronic immune conditions remain difficult to understand through diagnostic labels alone. Terms such as autoimmunity, autoinflammation, allergy, chronic inflammation, fibrosis, immunodeficiency, and post-infectious illness describe important patterns, but they do not always explain how the living organism became stuck in those patterns.
The paper reframes immunity as the organism’s living boundary-coherence process. Immunity is not primarily a war against non-self. It is the way a living organism conserves its identity while remaining open to nourishment, microbes, air, relation, repair, learning, and participation. The immune system must defend without becoming permanently defended, tolerate without becoming vulnerable, repair without overbuilding, remember without fixation, and return to ordinary life after perturbation.
The central concept is maladaptive organism–niche phase-locking. In health, the organism moves through adaptive phases: surveillance, boundary sensing, danger detection, defence, containment, resolution, clearance, repair, memory, and re-entry into the health cycle. In chronic disease, one or more of these phases becomes locked. Inflammation persists after its work should be complete. Debris, immune complexes, damaged mitochondria, mucus, crystals, toxins, matrix fragments, or biofilms remain uncleared. Repair becomes fibrosis. Memory becomes hypervigilance. Fatigue and pain become persistent conservation states. The organism cannot re-enter ordinary rhythms of sleep, movement, nourishment, relation, and participation.
The framework integrates several bodies of knowledge. Autopoiesis and organism–niche unity provide the living-systems foundation. 5E cognition reframes immunity as embodied, embedded, enactive, extended, and evaluative sense-making. Salutogenesis explains the coherence, resources, and meaning needed for health. Salugenesis describes the biological generation of healing. Allostasis and allostatic load explain how adaptation becomes costly when recovery is incomplete. Immunometabolism and mitochondrial biology show how energy, redox state, chromatin, and danger signalling shape immune phases. Tissue-niche science explains why diseases take specific forms in the airway, gut, skin, synovium, enthesis, vessel, kidney, lung interstitium, bone marrow, and nervous system.
Clinically, the paper proposes that diagnosis should become phase-state reasoning. Physicians should still name the disease according to established clinical standards, but they should also ask what regulatory lock is dominant. Is the patient locked in recognition and misrecognition, innate danger sensing, interferon alarm, viral boundary disturbance, type 2 barrier inflammation, mechano-inflammatory enthesitis, immune-complex vascular injury, trained innate readiness, immune deficiency with dysregulation, failed clearance, fibrosis, or neuroimmune pain-fatigue conservation? This second layer of reasoning helps identify what transition has failed and what kind of treatment may be needed next.
Treatment is reframed as phase restoration. Suppression is necessary when immune activity is destructive. Resolution is needed when inflammation cannot complete. Clearance is required when danger material remains. Repair is needed when tissue integrity has been lost. Reintegration is needed when the organism cannot return to ordinary health-cycle participation. The aim is not to force the organism back to normal, but to create the conditions under which the next coherent movement becomes possible.
The public health implications are equally important. Bodies do not heal in abstraction. They heal in air, housing, food systems, microbial ecologies, work rhythms, social relations, climate conditions, and care systems. Polluted air, unsafe housing, disrupted sleep, ultra-processed food systems, toxic exposures, chronic psychosocial threat, climate instability, and fragmented care may repeatedly interrupt healing-cycle completion. Public health is therefore reframed as the protection of health-cycle conditions at population scale.
At the civilizational level, chronic immune disease becomes a signal of organism–niche incoherence. A civilization is life-coherent when its institutions protect the conditions under which organisms can complete adaptive cycles. It becomes pathogenic when it normalizes chronic perturbation and then medicalizes the resulting phase-locks. The paper therefore connects clinical immunology to a wider question: what kind of world allows living beings to defend, resolve, clear, repair, reintegrate, and flourish?
The framework remains deliberately humble. It does not replace conventional diagnosis, urgent treatment, disease-specific mechanisms, or evidence-based medicine. It does not claim that all chronic disease is immune disease, that all immune disease has one cause, or that exposure, mitochondria, microbiome, stress, virome, or civilization explains everything. Its contribution is a deeper clinical grammar: a way of seeing chronic immune disease as unfinished living, where the task of medicine is to understand the lock, support the next adaptive transition, and help life move again.
Summary of Immune Phase-Locks and Biological Mechanisms
Please scroll to the right to see the right columns| Phase-Lock Pattern | Core Unfinished Process | Biological Mechanisms | Tissue and Clinical Examples | Therapeutic Priority |
|---|---|---|---|---|
| Recognition / Misrecognition Lock (Identity Lock) | Persistent mis-evaluation of self, altered self, or harmless structures as threat; tolerance and clearance fail to resolve. | Breakdown of tolerance; altered antigen presentation; epitope spreading; molecular mimicry; aberrant B/T cell activation. | Autoimmune diseases (e.g., SLE, RA, type 1 diabetes), graft rejection, vitiligo. | Re-establish tolerance, reduce tissue damage, and regulate recognition and co-stimulation. |
| Danger / Inflammasome Lock (Pyroinflammatory Lock) | Persistent danger signaling and inflammasome activation without adequate resolution. | DAMP excess; ATP release; NLRP3 inflammasome activation; IL-1 $\beta$ /IL-18 amplification. | Gout, cryopyrin-associated periodic syndromes (CAPS), sterile inflammation states. | Reduce danger signaling, target inflammasome pathways, and restore resolution. |
| Nucleic Acid / Interferon Lock (Antiviral-Like Lock) | Persistent detection of nucleic acids or self-nucleic acid sensing with IFN dominance. | cGAS–STING activation; TLR3/7/9 signaling; endogenous retroelements; IFN-I signature. | SLE, dermatomyositis, Aicardi-Goutières syndrome, long viral states, chilblain lupus. | Reduce IFN drive, clear nucleic acid sources, and restore immune quietude. |
| Barrier / Type 2 / Allergic Lock (Barrier Alarm Lock) | Barriers remain activated; type 2 inflammation persists; repair and tolerance are blocked. | IL-4/IL-13 axis; epithelial alarmins (IL-33, TSLP); IgE; barrier microbiome dysbiosis. | Asthma, atopic dermatitis, chronic rhinosinusitis with polyps, eosinophilic esophagitis. | Restore barrier ecology, reduce type 2 inflammation, and promote tolerance. |
| Enthesis / IL-17 / Mechano-Inflammatory Lock | Mechanical stress–inflammation loop sustains IL-17/IL-23 axis and tissue activation. | IL-23/IL-17 axis; entheseal stress; microdamage; barrier breach; innate lymphoid cell activation. | Axial spondyloarthritis, psoriatic arthritis, reactive arthritis. | Reduce mechano-inflammatory load, target IL-23/IL-17, and restore barrier and tolerance. |
| Immune Complex / Vascular Lock (Immune-Complex Lock) | Persistent immune-complex formation, deposition, and complement activation. | Autoantibodies; complement activation; FC receptor signaling; impaired clearance. | Lupus nephritis, vasculitides, cryoglobulinemia, serum sickness–like states. | Reduce immune complex formation, enhance clearance, and control complement injury. |
| Trained Immunity / Epigenetic Reprogramming Lock (Inflammatory Readiness Lock) | Innate cells remain epigenetically reprogrammed toward pro-inflammatory readiness. | Metabolic reprogramming; H3K4me3/H3K27ac marks; mTOR–HIF-1 $\alpha$ –glycolysis; $\beta$ -glucan and LPS exposures. | Metabolic syndrome, atherosclerosis, NAFLD/NASH, chronic infections (e.g., TB), aging. | Reprogram metabolism, use epigenetic modulators, and reduce persistent microbial stimuli. |
| Resolution / Clearance Failure Lock (Debris-Persistence Lock) | Apoptotic and necrotic debris persist; resolution programs remain incomplete. | Efferocytosis failure; Mertk/AXL defects; complement dysregulation; resolvins/maresins deficiency. | Long COVID, chronic rhinosinusitis, rheumatic disease, atherosclerosis. | Enhance clearance, restore resolution mediators, and complete the healing cycle. |
| Repair / Fibrosis / Matrix Overbuild Lock (Repair-Overbuild Lock) | Repair programs become excessive; fibrosis replaces functional tissue. | TGF- $\beta$ /SMAD signaling; myofibroblast activation; ECM deposition; hypoxia. | Pulmonary fibrosis, liver fibrosis, systemic sclerosis, retroperitoneal fibrosis. | Anti-fibrotic strategies, reduce TGF- $\beta$ signaling, and promote matrix remodeling. |
| Neuroimmune / Allostatic Lock (Neuroimmune Lock) | Neuroimmune and allostatic systems remain in threat mode and cannot reset. | Microglial priming; HPA axis dysregulation; vagal tone reduction; autonomic imbalance; cytokine-neurotransmitter interactions. | ME/CFS, fibromyalgia, POTS, long COVID, central sensitization syndromes. | Restore safety and rhythm, address autonomic tone, and reduce neuroinflammation. |
